In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Expected publication date

Expected publication date

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 111 to 120 of 366

TitleTypeExpected publication date
Elamipretide for treating Barth syndrome in people of any age [ID6545]Technology appraisal guidanceTBC
Elexacaftor–tezacaftor–ivacaftor with ivacaftor for treating cystic fibrosis without an F508del mutation and with a mutation in the CFTR gene that is responsive to elexacaftor–tezacaftor–ivacaftor in people aged 6 and over [TSID11847]Technology appraisal guidanceTBC
Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatments (managed access review of TA1023) [ID6653]Technology appraisal guidance
Endoscopic submucosal dissection knives for the resection of complex colorectal polyps with suspected submucosal invasionHealthTech guidance
Endouterine-ultrasound guided transcervical radiofrequency ablation for fibroidsHealthTech guidanceTBC
Enfortumab vedotin for treating locally advanced or metastatic urothelial cancer after 2 therapies [ID3845]Technology appraisal guidance
Epcoritamab with rituximab and lenalidomide for treating relapsed or refractory follicular lymphoma after 1 or more systemic treatments [ID6586]Technology appraisal guidance
Epilepsies in children, young people and adults (extraordinary review)NICE guidelineTBC
Epilepsies in children, young people and adults (SeLECTS)NICE guideline
ERC1671 for treating progressed or recurrent grade IV glioma (glioblastoma or gliosarcoma) [ID1623]Technology appraisal guidanceTBC

Results per page

  1. 10
  2. 25
  3. 50
  4. All